Interstim Implant – Stage II

Anesthesia Implications

Position: Prone, arms tucked
Time: 30-60 min (short)
Blood Loss: Very Low (5-10 ml)
Post-op Pain: Minimal (1-3)
Maintenance Paralytic: Contraindicated
Lead: Yes

Anesthetic Approaches

  • GETT
The Anesthesia

muscle relaxants are contraindicated – The surgeon will be testing sacral nerves and muscle relaxants will interfere with this.

Tucked Arms (general considerations): Consider a second IV – once the procedure has started, it’s going to be VERY difficult to handle IV issues – especially if your only IV has problems. Ensure the IV is running and monitors are still functioning after tucking the patient’s arms

Prone Position (general considerations): Maintain cervical neutrality. Keep IV’s out of the antecubital space. The patients arms are typically flexed, which will kink the IV. Eye protection should be used as the prone position heightens the risk of corneal abrasion and/or traction on the globe (which can result in blindness). Check the patients eyes/ears/nose regularly throughout the case to ensure they are free of pressure. Positioning of the leads is typically high on the posterior and posterolateral back (somewhere free of pressure and out of surgical borders). Keep your connections and tubing where you’ll have fast access.

Fluoroscopy / Xray (general considerations): Have lead aprons and thyroid shields available. Alternatively, distancing yourself 3 to 6 feet will reduce scatter radiation to 0.1% to 0.025% respectively. Occupational maximum exposure to radiation should be limited to a maximum average of 20 Sv (joules per kilogram – otherwise known as the Sievert/Sv) per year over a 5 year period. Limits should never exceed 50 Sv in a single year.

The Surgery

In this procedure, a device will be surgically placed just under the skin in the upper lateral buttocks. This device is designed to stimulate the S2 – S4 sacral nerves. Impulses to these nerve roots are designed to suppress the overactive nerves of the bladder.

Leads were previously placed to test the efficacy of the stimulation (Stage I). The stimulation proved to be effective, so the device is being permanently placed.

Placement of the interstim device is designed to treat overactive bladder, incontinence, and non-obstructive urinary retention.

In some patients, a negative affect of the stimulation is loss of bladder control.